Offices:
Espoo
Investors:
we tracked 2 investors
You need an account to access this feature.
Login or create one from
here.
(it takes 20 seconds)
Total investments received (USD) - we tracked 3 transactions
You need an account to access this feature.
Login or create one from
here.
(it takes 20 seconds)
Established in 2000, Mobidiag develops innovative solutions to advance the diagnosis of infectious diseases and serves the European clinical diagnostics market since 2008.
Mobidiag is headquartered in Espoo, Finland, with a subsidiary in Paris, France.
In 2013, Mobidiag merged with a diagnostic platform developer Genewave and a stool-based clinical assay development company Amplidiag, complementing our capabilities in developing and offering industry-leading diagnostic solutions and solidifying our position in the field of molecular diagnostics.
Companies with similar profile to Mobidiag:
| Company | Criteria |
|---|
 Galecto Biotech54% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
 Aprea Therapeutics54% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| ITBMed 54% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
 BC Platforms54% | - Similar verticals: Health services
- Similar business models: B2B, SAAS
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
 Alvotech54% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| Blueprint Genetics 54% | - Similar verticals: Health services
- Similar business models: B2B, SAAS
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| Glucostratus (Mendor) 54% | - Similar verticals: Health services
- Similar business models: B2B, SAAS
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
 Oncoinvent54% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| NMD Pharma 54% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| Monocl 45% | - Similar verticals: Biotech, Health services
- Similar business models: B2B, SAAS
|
| Vint 44% | - Similar verticals: Health services
- Similar business models: B2B, SAAS
- Minim one investor from outside Scandinavia: Yes
|
| Mentis Cura 44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
| TILT Biotherapeutics 44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
| CysBio 44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Minim one investor from outside Scandinavia: Yes
|
| Optomed 44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Minim one investor from outside Scandinavia: Yes
|
| Chundsell Medicals 44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Minim one investor from outside Scandinavia: Yes
|
| Cavidi 44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
| Doktor.se 44% | - Similar verticals: Health services
- Similar business models: B2B, SAAS
- Total raised in a similar range: 10M+ USD
|
| MinervaX 44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
| Megical 44% | - Similar verticals: Health services
- Similar business models: B2B, SAAS
- Minim one investor from outside Scandinavia: Yes
|
